FAM
ATNM icon

Formidable Asset Management’s Actinium Pharmaceuticals ATNM Stock Holding History

Formidable Asset Management’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-333
Closed -$2K – 233
2019
Q3 		$2K Hold
333
– – ﹤0.01% 123
2019
Q2 		$2K Buy
+333
New +$3.35K ﹤0.01% 216

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Formidable Asset Management's ATNM Position: Q4 2019 in Review

Formidable Asset Management sold out of Actinium Pharmaceuticals (ATNM) in Q4 2019, closing a stake of 333 shares — an estimated $2K sold.

Formidable Asset Management first reported a position in ATNM in Q2 2019 and held it in 2 quarters. The position peaked at $2K in Q3 2019. 45 funds tracked by Wall St. Rank hold ATNM as of Q4 2019.

  • Formidable Asset Management reported no remaining Actinium Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Formidable Asset Management sold 333 Actinium Pharmaceuticals shares in Q4 2019, an estimated $2K.
  • Formidable Asset Management first reported a position in Actinium Pharmaceuticals in Q2 2019 and held it in 2 quarters.
  • Formidable Asset Management's Actinium Pharmaceuticals position peaked at $2K in Q3 2019.
  • 45 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q4 2019.

Based on Formidable Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.